Experienced, tenacious, and always trial-ready, we are committed to understanding complex legal challenges that impact the future of our clients’ businesses, globally.
Focusing on antitrust, intellectual property, and high-stakes litigation, our extensive teams in the U.S. possess deep knowledge and client-side experience across a range of sectors, including technology, healthcare, life sciences, and consumer products.
With a strong culture of diversity, equity, and inclusion, we build relationships with our clients and colleagues alike, helping communities and acting with purpose. Our client service, entrepreneurialism, and inquisitive nature sit at the heart of the firm, enabling us to prioritize client goals and achieve successful outcomes.
Partner Lisl Dunlop speaks with Mark Seidman, partner at Weil Gotshal & Manges LLP, for the American Health Law Association's Speaking of Health Law podcast about some of the potential health care antitrust priorities of a second Trump Administration...
Partner Lisl Dunlop speaks withMark Seidman, partner at Weil
Gotshal & Manges LLP, for the American Health Law
Association'sSpeaking of Health Lawpodcast about some
of the potential health care antitrust priorities of a second Trump
Administration. They discuss the incoming administration's
potential approaches to the new Merger Guidelines, hospital merger
enforcement, focus on labor market impacts, private equity in
health care, and the FTC's rule banning non-competes.
Originally published December 20, 2024
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
